Clinical Trial Update: QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy [Phase 1, Phase 2]

View source ↗

Summary

The QUILT-3.046 trial evaluating the NANT Melanoma Vaccine in combination immunotherapy for melanoma patients who progressed after chemotherapy and PD-1/PD-L1 t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• NANT Melanoma Vaccine

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Melanoma | Phase 1, Phase 2 | Status: WITHDRAWN